Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of reducing the effects of aging-associated impairment of neurogenesis comprising modulating c-c chemokine receptor type 3 (CCR3)

Method of reducing the effects of aging-associated impairment of neurogenesis comprising modulating c-c chemokine receptor type 3 (CCR3)

US Patent 11236340 · Granted Feb 1, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and compositions to maintain stem cell quiescence2025
Methods for proteome labeling2024
Method of treating aging-associated cognitive impairment by reducing CCR32024
Method of treating aging-associated cognitive impairment by reducing CCR32024
Method of treating aging-associated cognitive impairment by reducing CCR32024
Method of treating aging-associated cognitive impairment by reducing CCR32024
Method of treating aging-associated cognitive impairment by reducing CCR32024
Compositions and methods for treating age-related diseases2024
Methods and compositions to maintain stem cell quiescence2023
Methods and compositions for treating aging-associated conditions2021
VCAM-1 mediated methods and compositions for treating aging-associated impairmen2021
Methods for screening human blood products comprising plasma using immunocomprom2021